Summit Therapeutics Cash Flow Statement (2017-2026) | SMMT

Cash Flow Statement Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Mar2019 Jul2019 Sep2019 Oct2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-19.60M-27.10M-22.45M-13.35M-17.63M-23.20M-544.51M-19.28M-23.41M-39.11M-45.51M-62.72M-60.83M-72.92M
Depreciation and Depletion (Quarter)
0.08M0.08M0.07M0.10M0.09M0.09M0.09M0.05M0.03M0.03M0.03M0.02M0.02M0.02M0.03M0.04M0.04M0.04M0.04M0.05M
Share-based Compensation (Quarter)
5.62M4.00M2.50M2.76M2.66M2.77M4.25M0.70M8.75M9.51M11.09M19.37M11.02M11.10M478.78M130.76M111.78M72.79M68.71M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
8.47M0.47M
Cash from Operations (Quarter)
-23.57M-9.18M-19.00M-19.22M-8.55M5.19M-13.13M-29.27M-14.90M-19.46M-30.13M-33.00M-30.30M-48.67M-61.17M-66.74M-93.08M-101.94M-122.29M-141.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
2.90M-1.19M0.21M0.40M1.60M2.92M-2.35M2.97M1.02M3.02M4.22M2.97M
Amortization of Deferred Charges (Quarter)
0.29M0.34M0.30M0.26M0.40M0.29M0.28M0.42M0.57M0.57M
Depreciation & Amortization (CF) (Quarter)
0.08M0.08M0.07M0.10M0.09M0.09M0.09M0.05M0.03M0.03M0.03M0.02M0.02M0.02M0.03M0.04M0.04M0.04M0.04M0.05M
Change in Working Capital
Change in Receivables (Quarter)
1.37M-0.93M-0.46M-0.70M-1.23M1.41M-0.35M-0.01M-0.00M
Change in Account Payables (Quarter)
-1.02M-1.36M2.76M-3.48M-1.04M-2.37M0.31M0.30M2.33M-0.67M3.70M-3.04M-0.18M1.53M0.36M17.93M-0.84M-2.15M6.80M-3.91M
Change in Accured Expenses (Quarter)
-0.42M1.76M-3.52M0.44M7.90M-0.04M-3.24M-4.29M-0.20M5.35M-2.23M5.93M5.89M2.28M-7.59M14.04M0.94M5.53M12.22M20.74M
Other Working Capital Changes (Quarter)
0.28M-0.19M0.37M1.04M-1.97M-4.55M-0.51M1.43M2.46M-6.99M2.08M-3.12M0.09M8.33M-1.85M1.93M-3.74M8.53M11.01M12.03M
Investing Activities
Capital Expenditures (Quarter)
-0.00M0.12M0.36M0.29M-0.02M-0.01M0.05M0.02M0.05M0.00M-2.45M0.00M-0.01M2.60M1.42M2.25M0.86M-3.87M1.03M0.22M
Change in Acquisitions & Divestments (Quarter)
38.17M109.42M60.57M112.86M70.00M74.00M232.98M160.53M150.81M177.29M448.80M
Cash from Investing Activities (Quarter)
0.00M-0.12M-0.36M-0.29M0.02M0.01M-645.06M0.21M-3.49M60.57M19.87M-200.08M-108.61M83.48M160.11M150.81M-0.07M-485.16M-0.24M222.90M
Financing Activities
Other financing activities (Quarter)
0.73M1.22M0.19M0.11M0.10M0.65M0.23M4.12M0.48M199.51M234.96M-0.10M5.66M1.66M492.72M3.80M3.67M
Cash from Financing Activities (Quarter)
0.68M1.26M25.19M75.00M520.06M80.11M-0.08M0.23M6.25M0.48M200.21M204.14M-23.61M7.68M2.22M33.81M573.82M3.80M231.08M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
100.00M104.69M-0.62M0.62M43.04M-0.00M31.76M468.27M
Additional items
Exchange Rate Effect (Quarter)
-0.25M-0.42M-0.17M-0.60M-1.83M1.38M0.44M0.29M-0.17M0.27M-0.04M0.01M0.11M-0.11M0.04M0.06M0.02M-0.02M-0.02M0.00M
Change in Cash (Quarter)
-23.14M-8.46M5.66M-20.11M64.64M526.64M-577.64M-28.85M-18.32M47.63M-9.81M-32.86M65.34M11.09M106.66M86.35M-59.32M-13.29M-118.75M312.85M
Free Cash Flow (Quarter)
-23.56M-9.30M-19.36M-19.51M-8.54M5.20M-13.18M-29.29M-14.95M-19.46M-27.69M-33.01M-30.28M-51.27M-62.59M-69.00M-93.94M-98.07M-123.32M-141.34M
Net Cash Flow (Quarter)
-22.89M-8.04M5.83M-19.51M66.46M525.26M-578.08M-29.15M-18.15M47.36M-9.78M-32.87M65.23M11.20M106.62M86.29M-59.34M-13.27M-118.73M312.85M